Información del producto
NY2267 is an inhibitor of protein kinases that has shown promise in the treatment of tumors. It works by inducing apoptosis, or programmed cell death, in cancer cells. NY2267 is an analog of nintedanib, a drug used to treat idiopathic pulmonary fibrosis. Studies have shown that NY2267 inhibits the growth of various types of cancer cells, including those from Chinese hamster ovaries and human urine. This potent anticancer agent targets multiple kinases involved in tumor growth and development, making it a promising candidate for cancer therapy.
Propiedades químicas
Consulta técnica sobre: 3D-LKB05373 NY2267
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
